Literature DB >> 18516420

[Noncompliance with drug therapy for glaucoma].

Aldemar Nemesio Brandão Vilela de Castro1, Wander Araújo Mesquita.   

Abstract

INTRODUCTION: The treatment of glaucoma is made initially with the use of eyedrops, with the purpose to decrease intraocular pressure and to minimize the damages to the optic nerve. The lack of compliance with drug therapy can be influenced by factors related to patients, doctors and medicines. PURPOSES: To estimate the rate of noncompliance with the treatment with antiglaucoma eyedrops and to verify the intervenience of possible factors for noncompliance.
METHODS: A study of the transversal type was carried out, in the Ophthalmologic Clinic of the Hospital Governador Israel Pinheiro, in Belo Horizonte, Minas Gerais. Questionnaires were applied to 102 glaucoma patients to collect information about the level of noncompliance and the intervenience of possible factors for noncompliance with drug therapy.
RESULTS: The rate of noncompliance was 21.5%. The factors: not using the eyedrops due to money shortage (p=0.035) and accomplishment of corrective surgery (p=0.049), significantly contributed to noncompliance.
CONCLUSION: More than one fifth of the glaucoma patients does not follow the drug treatment in an adequate way. Donation of eyedrops to all the glaucoma patients without favorable economic conditions, governmental actions for the reduction of the prices of the eyedrops, information on the continuity of the use of the eyedrops after the accomplishment of corrective surgeries would help to decrease the rates of noncompliance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18516420     DOI: 10.1590/s0004-27492008000200014

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  4 in total

1.  Presentation of glaucoma in an urban tertiary care hospital in South America: legal blindness and prevalence.

Authors:  Tammy Hentona Osaki; Niro Kasahara; Mauricio Della Paolera; Ralph Cohen; Maria Cristina Nishiwaki-Dantas
Journal:  Int Ophthalmol       Date:  2010-02-25       Impact factor: 2.031

2.  Managing glaucoma in developing countries.

Authors:  Mauro Toledo Leite; Lisandro Massanori Sakata; Felipe Andrade Medeiros
Journal:  Arq Bras Oftalmol       Date:  2011 Mar-Apr       Impact factor: 0.872

3.  Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma.

Authors:  Yulong Wang; Yue Liao; Xin Nie
Journal:  Clinics (Sao Paulo)       Date:  2020-11-30       Impact factor: 2.365

4.  Real-world data from selective laser trabeculoplasty in Brazil.

Authors:  Ricardo Y Abe; Heloísa A Maestrini; Guilherme B Guedes; Marcelo M Nascimento; Camila I Iguma; Hérika Danielle de Miranda Santos; Muna Georges Nasr; Ricarte P Lucena-Junior; Tiago S Prata
Journal:  Sci Rep       Date:  2022-02-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.